Abstract
Recent approaches to management of infective endocarditis including recognition, empirical treatment, and etiological therapy depending on causative agent (streptococci, staphylococci, gram-negative bacteria, fungi and unknown etiology) are given in the article. Risk factors, diagnostic criteria and options for prophylaxis are described. Possible complications requiring additional therapy are discussed. Clinical and microbiological criteria for evaluation of efficacy of treatment are proposed.
-
1.
Sekido M., Takano T., Takayama M., et al. Survey of infective endocarditis in the last 10 years: analysis of clinical, microbiological and therapeutic features. J Cardiol 1999; 33:209-15.
-
2.
Bayer A.S. Revised diagnostic criteria for infective endocarditis. Cardiol Clin 1996; 14:345-50.
-
3.
Backes R.J., Wilson W.R., Geraci J.E. Group B streptococcal infective endocarditis. Arch Intern Med 1984; 145:693-6.
-
4.
Weinstein M.P., Towns M.L., Quartey S.M., et al. The clinical significance of positive blood cultures in the 1990 s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24:584-602.
-
5.
Lindner J.R., Case R.A., Dent J.M., et al. Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease. Сirculation 1996; 93:730-6.
-
6.
Durack D.T., Bright D.K., Lukes A.S., Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-9.
-
7.
Wason W.S. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274:1706.
-
8.
Wilson W.R. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci. Clin Microbiol Infect 1998; 4 (Suppl 3): 17-26.
-
9.
Backes R.J., Rouse R.S., Henry N.K., et al. Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis. J Antimicrob Chemother 1986; 18:491-8.
-
10.
Huminer D., Bishara J., Pitlic S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999; 18:330.
-
11.
Francioli P., et al. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study. Clin Infect Dis 1995; 21:1406.
-
12.
Eliopoulos G.M. Aminoglycoside resistant enteroccocal endocarditis. Infect Dis Clin North Am 1993; 7:717.
-
13.
Spara R.V., Farber B.F. Multiple-resistant Enterococcus faecium. JAMA 1992; 268:2563.
-
14.
Buch L.M. High-level penicillin resistance among isolates of enterococci. Ann Intern Med 1989; 110:505-515.
-
15.
Nortara L.A., Bayer A.S. Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am 1993; 7:57-68.
-
16.
Sandre R.M., Shafran S.D. Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 1996; 22:276-86.
-
17.
Tornos M.P., Permanger-Miralda G., Planes-Reig A., et al. Long term follow up of native valve infective endocarditis. Eur Heart J 1995; 16:1086-91.
-
18.
Tornos M.-P., Permanger-Miralda G., Olona M., et al. Long term complication of native-valve infective endocarditis in non-addicts. Ann Intern Med 1992; 117:567-73.
-
19.
Rubinstein E., Carbon C. Staphylococcal endocarditis – recommendations for therapy. Clin Microbiol Infect 1998; 4 (Suppl 3):27-33.
-
20.
Von Scoy RE. Culture-negative endocarditis. Mayo Clin Proc 1982; 57:149.
-
21.
Leport C. Antibiotic prophylaxis for infective endocarditis. Clin Microbiol Infect 1998; 4 (Suppl 3):56-61.
-
22.
Демин А.А., Дробышева В.П. Цефтриаксон в лечении стафилококкового эндокардита. Антибиотики и химиотер 1998; 43(6):12-15.